AP NEWS

T2 Biosystems to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum

November 8, 2018

LEXINGTON, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that John McDonough, president and chief executive officer, is scheduled to present at the Canaccord Genuity Medical Technologies & Diagnostics Forum. The conference is being held on November 15 at the Westin Grand Central in New York.

Mr. McDonough is scheduled to present on Thursday, November 15, 2018 at 11:00 a.m. ET. Mr. McDonough and John Sprague, chief financial officer, will be available for one-on-one meetings during the conference. The presentation will be webcast live and available for replay, and may be accessed by visiting the Investors/Events & Presentations section of the Company’s website at www.t2biosystems.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company’s website for 90 days following the presentation.

About T2 Biosystems:T2 Biosystems, a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems’ products include the T2Dx® Instrument, T2Candida® Panel, and T2Bacteria® Panel, and are powered by the proprietary T2 Magnetic Resonance (T2MR®) technology. T2 Biosystems has an active pipeline of future products, including products for the detection of additional species and antibiotic resistance markers of sepsis pathogens, and tests for Lyme disease. For more information, please visit www.t2biosystems.com.

Media Contact: Gina Kent, Vault Communicationsgkent@vaultcommunications.com610-455-2763

Investor Contact:Zack Kubow, W2O Groupzkubow@w2ogroup.com415-946-1053

AP RADIO
Update hourly